Sun Pharma Announces Regulatory Filing of Tildrakizumab in Japan EP News Bureau Aug 1, 2019 Japan is a key market with approximately 430,000 people currently suffering from psoriasis and psoriatic arthritis
Sun Pharma and CMS enter into a License Agreement for Cyclosporine A and Tildrakizumab in Greater… EP News Bureau Jun 27, 2019 Under the terms of the license agreement, CMS will pay Sun Pharma an initial upfront payment, regulatory and sales milestone…
Sun Pharma announces positive results of two phase-III CTs of Tildrakizumab Usha Sharma May 4, 2016 The IL-23p19 Therapeutic Antibody meets primary endpoints in both placebo-controlled studies and secondary endpoint in…
